| Literature DB >> 34558192 |
Quanchen Xu1, Yuanxin Miao2, Jizheng Ren2, Yu Sun2, Cong Li2, Xia Cai2, Zhiguo Wang2.
Abstract
Mechanical force plays a pivotal role in the pathogenesis of hypertrophic scar (HTS). Dermal fibroblasts and myofibroblasts are the key cells involved in HTS. Myofibroblasts in HTS possess different biochemical and biophysical characteristics by which myofibroblasts are often distinguished from fibroblasts. The role of mechanotransducers outside the nucleus in the pathogenesis of HTS has been reported in many studies. However, the role of Nesprin-2 in HTS is not clear. Hence, we aim to construct a cell model of HTS and explore the role of Nesprin-2 in this process. Myofibroblasts and fibroblasts were isolated from HTS and healthy skin tissues of the same patient. Fibroblasts were exposed to cyclic stretch with 10% magnitude and a frequency of 0.1 Hz for 3 days, 5 days, and 7 days, respectively. After the cell model was confirmed, fibroblasts transfected with siRNA targeting human Nesprin-2 were exposed to cyclic stretch. The mechanical behaviour and biochemical reaction of the dermal fibroblasts were analysed. The stretched fibroblasts at day 5 showed the same mechanotransductive and biochemical features as unstretched myofibroblasts. Mechanical strain could induce the myofibroblasts differentiation and a cell model of HTS was established successfully at day 5. The expressions of lamin A/C, alpha-smooth muscle actin, transforming growth factor beta 1, and collagen type I in fibroblasts were reduced by the silencing of Nesprin-2. Mechanical strain could induce the myofibroblasts differentiation and silencing of Nesprin-2 could block the mechanical stimulation of terminal myofibroblasts differentiation. Nesprin-2 might be a potential target to treat the HTS.Entities:
Keywords: Nesprin; cyclic stretch; differentiation; hypertrophic scar; myofibroblasts
Mesh:
Substances:
Year: 2021 PMID: 34558192 PMCID: PMC9284660 DOI: 10.1111/iwj.13694
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.099
The data of patients providing the hypertrophic scar (HTS) and healthy skin tissues
| Patients | Gender | Age (years) | Location of HTS tissues | Location of healthy skin tissues (skin graft) | Size of a biopsy |
|---|---|---|---|---|---|
| No. 1 | male | 27 | right elbow | Right groin | 5 mm in diameter |
| No. 2 | female | 37 | right wrist | Inferior abdominal wall | |
| No. 3 | female | 18 | Face | Left upper arm |
List of primer pairs used for quantitative reverse transcription PCR
| Gene Sequences (5′‐3′) | ||
|---|---|---|
| Integrin β1 | F: ACAATGGAGAGTGCGTCTGC | R: CGTTGCTGGCTTCACAAGTA |
| a‐SMA | F: CAATGTCCCTGCCATGTACGTC | R: GGCAGGGCATAGCCTTCATAGA |
| Nesprin‐2 | F: CAGTCCTTACAACTCCTGGACAC | R: GACTGATTCTCCTACCCACAGAC |
| Lamin A/C | F: AGCCCCCAGAACTGCAGCATCATGTAA | R: TTACATGATGCTGCAGTTCTGGGGGCT |
| TGF β1 | F: ATTCCTGGCGATACCTCAG | R: AAGGCGAAAGCCCTCAAT |
| COL1A1 | F: CCTGGAAAGAATGGAGATGATG | R: ATCCAAACCACTGAAACCTCTG |
| GAPDH | F: TCACCATCTTCCAGGAGCGA | R: CACAATGCCGAAGTGGTCGT |
Abbreviations: a‐SMA, alpha‐smooth muscle actin; COL1A1, collagen type I, α 1 chain; GAPDH, glyceraldehyde‐3‐phosphate dehydrogenase; TGFβ1, transforming growth factor beta 1.
FIGURE 1Reactions of cells to cyclic stretch at different time. (A) Cell proliferation ability. (B) The protein levels of integrin β1 and Nesprin‐2 detected by western blotting. (C) The mRNA expression levels of integrin β1 and Nesprin‐2 detected by RT‐PCR. (D) The mRNA expression and protein levels of collagen type I detected by RT‐PCR and ELISA. (E) The mRNA expression and protein levels of TGF‐β1 detected by RT‐PCR and ELISA. (i) SF: Stretched Fibroblasts; (ii) USF: unstretched fibroblasts; (iii) USM: unstretched myofibroblasts. Error bar: ±SD (n = 3); *P < 0.05; **P > 0.05
FIGURE 2Detection of α‐SMA expression in cells at different time. (A) α‐SMA expression (Green) and nuclei staining (Blue) detected by immunofluorescence assay. Scale bars: 50 μm. (B) The mRNA expression levels of α‐SMA detected by RT‐PCR. (C) The protein levels of α‐SMA detected by western blotting. (i) SF: stretched fibroblasts; (ii) USF: unstretched fibroblasts; (iii) USM: unstretched myofibroblasts. Error bar: ±SD (n = 3); *P < 0.05; **P > 0.05
FIGURE 3Reactions of cells to cyclic stretch with 10% magnitude at day 5. (A) Cell proliferation ability. (B) The mRNA expression levels of TGF‐β1 and collagen type I detected by RT‐PCR. (C) The protein levels of TGF‐β1 and collagen type I detected by ELISA. (D) The protein levels of a‐SMA, Nesprin‐2, and lamin A/C detected by western blotting. (E) The mRNA expression of a‐SMA, Nesprin‐2, and lamin A/C detected by RT‐PCR. (i) SF: stretched fibroblasts; (ii) SF + siRNA: SF transfected with siRNA; (iii) USM: unstretched myofibroblasts. Error bar: ±SD (n = 3); *P < 0.05; **P > 0.05